Don't use DIABETES as a CV risk equivalent
As a pharmacy doctor, you will see more consensus on using statins for diabetes…
August 08, 2024
0 Comment
Cardiovascular Medicine
Don't use DIABETES as a CV risk equivalent
Optimizing meds in patients with HFrEF and CKD
Few patients with chronic kidney disease (CKD) are on optimized meds for heart…
May 24, 2024
0 Comment
DAPT after an ischemic stroke or TIA?
New data will raise questions about optimal use of short-term dual antiplatelet…
May 14, 2024
0 Comment
Know COLCHICINE's role in chronic coronary disease
As a cardiovascular pharmacist, you’ll hear buzz about new Rx colchicine ( Lodo…
May 12, 2024
0 Comment
FAQs on First-Line BP Meds
As a clinical pharmacist, you often encounter questions about choosing blood p…
April 24, 2024
0 Comment
Guide use of BP meds during pregnancy
As a cardiovascular pharmacist, more questions arise about managing chronic hyp…
April 16, 2024
0 Comment
Angiotensin-converting enzyme (ACE) inhibitors
Therapeutic actions ㅡ ACE inhibitors block ACE in the lungs from converting ang…
September 01, 2023
0 Comment
HFpEF Treatment Options
As a clinical pharmacy specialist, you will get questions about managing heart …
June 30, 2023
0 Comment
DAPT duration for patients at HIGH bleeding risk
As a cardiovascular pharmacist, you will hear debate about shorter dual antipla…
June 24, 2023
0 Comment
Can we use fondaparinux in RENAL patients?
As a clinical pharmacy specialist, it is important to address the safety of usi…
June 16, 2023
0 Comment
Subscribe to:
Posts (Atom)